4.2 Article

Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare

期刊

JOURNAL OF BIOCHEMISTRY
卷 165, 期 2, 页码 139-158

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jb/mvy096

关键词

genome reference panel; Japonica array; personalized healthcare; Tohoku Medical Megabank Project; whole genome sequencing

资金

  1. Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology, Japan
  2. Reconstruction Agency, Japan
  3. Japan Agency for Medical Research and Development (AMED) [JP18km0105001, JP18km0105002]
  4. AMED Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) project [JP18km0405203]
  5. Center of Innovation Program from the Japan Science and Technology Agency (JST)
  6. Facilitation of R&D Platform for AMED Genome Medicine Support [JP18km0405001]

向作者/读者索取更多资源

Personalized healthcare (PHC) based on an individual's genetic make-up is one of the most advanced, yet feasible, forms of medical care. The Tohoku Medical Megabank (TMM) Project aims to combine population genomics, medical genetics and prospective cohort studies to develop a critical infrastructure for the establishment of PHC. To date, a TMM CommCohort (adult general population) and a TMM BirThree Cohort (birth + three-generation families) have conducted recruitments and baseline surveys. Genome analyses as part of the TMM Project will aid in the development of a high-fidelity whole-genome Japanese reference panel, in designing custom single-nucleotide polymorphism (SNP) arrays specific to Japanese, and in estimation of the biological significance of genetic variations through linked investigations of the cohorts. Whole-genome sequencing from >3,500 unrelated Japanese and establishment of a Japanese reference genome sequence from long-read data have been done. We next aim to obtain genotype data for all TMM cohort participants (> 150,000) using our custom SNP arrays. These data will help identify disease-associated genomic signatures in the Japanese population, while genomic data from TMM BirThree Cohort participants will be used to improve the reference genome panel. Follow-up of the cohort participants will allow us to test the genetic markers and, consequently, contribute to the realization of PHC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据